AnPac Bio-Medical Science Co., Ltd. announced that effective August 2, 2022, the board of directors appointed Jiawen Kang as a member of the board of directors of the Company and a member of the Audit Committee and Nominating Committee. On that date, the Company also appointed Yuyang Cui as Co-Chairman of the Board of the Company. As previously reported, on July 14, 2022, written resolutions were passed by a majority of the votes of all shareholders entitled to vote at a general meeting authorizing, among others, (1) the removal of Aidong Chen and Sheng Liu as members of the Board; (2) the removal of Aidong Chen as Co-Chairman of the Board and Co-Chief Executive Officer of the Company; and (3) the re-designation of Chris Chang Yu as Chief Executive Officer of the Company and Chairman of the Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.55 USD | -3.51% | -35.00% | -38.20% |
Mar. 21 | ADRs Edge Higher; Lufax Climbs Almost 46% | DJ |
Mar. 19 | ADRs End Flat, Ehang Holdings Ltd. Climbs 15.6% | DJ |
1st Jan change | Capi. | |
---|---|---|
-38.20% | 12.22M | |
+82.29% | 4.14B | |
-23.73% | 2.51B | |
-14.73% | 2.34B | |
-19.45% | 1.66B | |
+32.37% | 1.15B | |
+5.02% | 840M | |
-11.75% | 548M | |
-34.49% | 466M | |
+45.95% | 277M |
- Stock
- Equities
- Stock Fresh2 Group Limited - Nasdaq
- News Fresh2 Group Limited
- AnPac Bio-Medical Science Co., Ltd. Announces Executive Appointments